A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer
Clinical trial NCT05141357 · TERMINATED
Trial details
- NCT number
- NCT05141357
- Sponsor
- HUYABIO International, LLC.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2023-04-19
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.